Acireale, Italy

Anna Rita Blanco

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 9.4

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2001-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Anna Rita Blanco**

Introduction

Anna Rita Blanco, an accomplished inventor based in Acireale, Italy, is known for her groundbreaking contributions to the field of ocular therapeutics. With a portfolio of four patents, her work primarily focuses on developing nanostructured formulations for delivering active ingredients aimed at treating ocular diseases.

Latest Patents

One of Anna's latest patents involves innovative formulations that incorporate silibinin and other active ingredients within lipid nanoparticle systems of the Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) type. These formulations are designed with calixarenes, potentially mucoadhesive, and feature micellar and nanoparticle systems based on amphiphilic inulin copolymers. Such advancements target neurodegenerative ocular diseases by leveraging the versatility of calixarene compounds, which can effectively load and release active ingredients that are otherwise characterized by low water solubility and low bioavailability. This innovation holds significant promise for improving treatment efficacy in ocular therapies.

Career Highlights

Over her career, Anna has made significant strides in pharmaceutical research and development. She has worked with notable companies such as Distretto Tecnologico Sicilia Micro e Nano Sistemi S.c.a.r.l. and S.i.f.i. Società Industria Farmaceutica Italiana S.p.a., contributing to the advancement of nanotechnology applications in medicine.

Collaborations

Anna has collaborated with esteemed colleagues, including Gennara Cavallaro and Grazia Maria Letizia Consoli. These partnerships have undoubtedly enriched her research, fostering an environment of shared knowledge and innovation in the field of ocular pharmaceuticals.

Conclusion

Anna Rita Blanco's dedication to innovation is evident through her patents and collaborations, positioning her as a key figure in the development of novel therapeutic solutions for ocular diseases. Her work not only highlights the importance of nanotechnology in medicine but also paves the way for future advancements in treating complex conditions affecting vision.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…